Sanguina wins 3rd prize in the NIH Technology Accelerator Challenge for the design and development of AnemoCheck Mobile, a non-invasive, handheld, digital technologies to detect and diagnose sickle cell disease (SCD), malaria, and anemia.
AnemoCheck Mobile has the potential to be combined with key assessments for evaluation of malaria and sickle cell disease for populations who need it most.
Continue Reading
Sanguina wins 3rd prize in the NIH Technology Accelerator Challenge for the design and development of AnemoCheck Mobile, a non-invasive, handheld, digital technologies to detect and diagnose sickle cell disease (SCD), malaria, and anemia.